Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #2831 on Theralase Technologies Inc (TLTFF)
abun
05/26/17 9:44 AM
#2832 RE: was CUIN2 #2831
LJ Silver
05/31/17 8:40 AM
#2857 RE: was CUIN2 #2831
in accordance with the DSMB’s decision, is now recommended to enroll an additional six patients for the second part of the Study, treating them at a therapeutic dose of the PDC (0.70 mg/kg) for NMIBC using its novel Photo Dynamic Therapy (“PDT”) technology.